- Poorkiani M, Hazrati M, Abbaszadeh A, Jafari P, Sadeghi M, Dejbakhsh T, et al. Does a rehabilitation program improve quality of life in breast cancer patients? Payesh. 2010; 9(1): 61-8. (In Persian).
- Sajadian A, Kaviani A, Montazeri A, Haji Mahmodi M, Ebrahimi M, Samie F, et al. The use of complementary and alternative therapies in cancer patients. Payesh. 2004; 4(3): 197- 205. (In Persian).
- Mardani Hamule M, Shahraki Vahed A. Relationship between mental health and quality of life in cancer patients. JSSU. 2010; 18(2): 111-7. (In Persian).
- Yavari P, Mehrabi U, Pour-Hoseingholi M A. Knowledge and practice of women toward breast self-examination: A case-control study. J Ardabil Univ Med Sci. 2005; 5(4): 371-7. (In Persian).
- Sharafi A, Khoshgard K, Nikoofar A. Measurement of the absorbed dose by bladder and rectum in the radiation therapy of Prostate cancer by thermoluminescent dosimetry method. RJMS. 2009; 16(64): 7-13. (In Persian).
- Clay C, Perera S, Wagner J M, Miller M E, Nelson J B, Greenspan S L. Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther. 2007; 87(10): 1325-33.
- Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA- Cancer J Clin. 2005; 55(2): 74- 108.
- Newton R U, Taaffe D, Spry N, Gardiner R A, Levin G, Wall B, et al. Phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer. 2009; 9: 210.
- Mohammadi Falah M R, Jafari S, Alizade M, Mokhtari M R. The effect of intravesical BCG therapy on serum PSA level. Urmia Medical Journal. 2008; 2(19): 152- 7. (In Persian).
- Morgentaler A. Testosterone and Prostate cancer: What are the risks for middle-aged men? Urol Clin Am. 2011; 38: 119-24.
- Thampson I, Carroll, P, Coley C, Sweat G, Schellhammer P, Wasson J et al. Prostate-specific antigen (PSA) best practice policy American Urological Association (AUA). Oncology (Williston Park). 2000; 14: 267–72.
- Goldenberg S L, Koupparis A, Robinson M E. Differing levels of testosterone and the prostate: A physiological interplay. Nat Rev Uro. 2001; 8: 365- 77.
- Smith M R, Finkelstein J S, McGovern F J, Zietman A L, Fallon M A, Sch oenfeld D A, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002; 87: 599- 603.
- Drouin J S, Beeler J. Exercise and urologic cancers. Urologic Oncology. 2008; 26(2): 205-12.
- Liua S, Leea M, Linsona P, Ajania U, Buringa J E, Hennekense C H. A prospective study of physical activity and risk of prostate cancer in US physicians. Int J Epidemiol. 2009; 29(1): 29-35.
- Segal R J, Reid R D, Courneya K S, Malone S C, Parliament M B, Scott C G, et al. Resistance exercise in men receiving androgen deprivation therapy for Prostate cancer. J Clin Oncol. 2003; 21: 1653-59.
- Galvao D A, Nosaka K, Taaffe D R, Spry N, Kristjanson L J, McGuuigan M R, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exer. 2006, 38: 2045–52.
- Culos-Reed S N, Robinson J L, Lau H, O’Connor K, Keats M R. Benefits of a physical activity intervention for men with prostate cancer. J Sport Exer Psycho. 2007; 29: 118-27.
- Galvao D A, Taaffe D R, Spry N, Joseph D, Newton R U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for Prostate cancer without bone metastases: A randomized controlled trial. J Clin Oncol. 2010; 28: 340-7.
- Spirduso W W. Physical dimensions of aging. Human Kinetics: Champaign, IL; 2nd-Edition, 1995. P. 79.
- Shahinian V B, Kuo Y F, Freeman J L, Goodwin J S. Risk of fracture after androgen deprivation for prostate cancer. New Engl J Med. 2005; 352: 154-64.
- Kolden G G, Strauman T J, Ward A, Kuta J, Woods T E, Schneider K L, et al. A pilot study of group exercise training (GET) for women with primary breast cancer: Feasibility and health benefits. Psychooncology. 2002; 11(5): 447-56.
- Moritani T, DeVries H A. Potential for gross muscle hypertrophy in older men. J Gerontol. 1980; 5: 672–82.
- Greenspan S L, Coates P, Sereika S M, Nelson J B, Trump D L, Resnick N M. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocr Metab. 2005; 90(12): 6410-17.
- Segal R J, Reid R D, Courneya K S, Sigal R J, Kenny G P, Prudhomme D G, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009; 23: 344-51.
|